OC.40 Fibrotic ecm-targeting extracellular vesicles as mediators of systemic progression in systemic sclerosis
Shelly Tartakover Matalon(Tel Aviv University), Yair Levy(Meir Medical Center), Avshalom Shalom(Tel Aviv University), Ariel Berl(Meir Medical Center), Liat Drucker(Meir Medical Center), Elad Shashua(Meir Medical Center), Itzchak Amoyal(Meir Medical Center)
Cited by 0
Related Papers
High incidence of BRCA1–2 germline mutations, previous breast cancer and familial cancer history in Jewish patients with uterine serous papillary carcinoma
|European Journal of Surgical Oncology|2006|63
Overexpression of tetraspanins affects multiple myeloma cell survival and invasive potential
|The FASEB Journal|2007|56
Simvastatin has deleterious effects on human first trimester placental explants
|Human Reproduction|2005|51
Secretome of human bone marrow mesenchymal stem cells: an emerging player in lung cancer progression and mechanisms of translation initiation
|Tumor Biology|2015|48
BRCA1/2 Germline Mutations in Jewish Patients With Uterine Serous Carcinoma
|International Journal of Gynecological Cancer|2010|47